Abstract: An information processing device comprises bays to removably receive pluggable modules, a liquid cooling system comprising cold plates in the bays, and a module locking mechanism. The cold plates are movable between an engaged state with the pluggable modules and a disengaged state. The module locking mechanism prevents insertion and removal of the pluggable modules into or out of the bays if the cold plates are in the engaged state, and allows insertion/removal of the pluggable modules if the cold plates are in the disengaged state. The device may also comprise a cold plate engagement mechanism actuatable to move the cold plates between the engaged and disengaged states, and the module locking mechanism may be mechanically coupled to the cold plate engagement mechanism such that actuation of the cold plate engagement mechanism drives the module locking mechanism to switch between preventing and allowing insertion/removal.

Abstract: The present invention discloses a nutritional composition and method of using and making the nutritional composition. The nutritional composition is a hydrolyzed pea protein based nutrient composition for use in both enteral and oral feeding, and provides a non-allergenic diet for providing optimal nutrition to users. The nutritional composition is made from organic and plant-based ingredients. The nutritional composition has pea protein hydrolysates, phytochemical extracts, fatty acids, organic ingredients free of the top eight allergens and corn, and prebiotic fiber. The nutritional composition is provided in liquid form for enteral and/or oral feeding.

Abstract: Provided are therapeutic compositions containing Ecobiotic™ populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.

Abstract: Techniques and mechanisms for identifying unmanaged cloud resources with endpoint and network logs and attributing the identified cloud resources to an entity of an enterprise that owns the cloud resources. The process collects data from sources, e.g., endpoint and network logs, with respect to traffic in a computer network and based at least in part on the data, extracts relationships related to the traffic. The process applies rules to the relationships to extract destinations in the computer network that provide cloud resources in a cloud environment, wherein the cloud resources are owned by an enterprise. One or more users or business entities of the enterprise are identified as accessing the cloud resources.

Abstract: Methods and system for determining a similarity relationship between a plurality of digital assets and a target digital asset comprises creating a normalized semantic feature vector associated with a search query, discovering the target asset based on the normalized semantic feature vector, generating a normalized latent feature vector associated with the target asset, comparing the normalized semantic feature vector with semantic feature vectors for each of the digital assets to generate a semantic comparison value, comparing the normalized target latent feature vector with latent feature vectors for each of the digital assets to generate a latent comparison value, blending the semantic comparison vector value with the latent feature comparison vector value to create a target comparison value for each of the digital assets, and reporting the digital assets having the highest target comparison values to the user or group of users.

Abstract: A therapeutic agent delivery device includes a disposable portion and a reusable portion that detachably carries the disposable portion. The reusable portion includes a drive mechanism. The drive mechanism thereby translates a syringe assembly of the disposable portion from a stowed configuration to a deployed configuration. A user input actuates the drive mechanism. The user input includes a first configuration and a second configuration prior to actuation. In the first configuration, the drive mechanism is inhibiting actuation of the user input, and in the second configuration the drive mechanism is permitting actuation of the user input. A method of moving a user input of a therapeutic agent delivery device is also described, including sensing aspects of the device prior to allowing the user input to be actuatable.

Abstract: Methods and compositions for populating the gastrointestinal tract of a subject are described. Methods include administering to a subject a therapeutic composition comprising a purified population of spore-forming bacteria produced by providing a fecal material and subjecting the material to a treatment step resulting in purification of spore-forming bacteria. Methods include administering an amount effective to engraft and/or augment in the gastrointestinal tract in order to treat or prevent a dysbiosis in the mammalian subject.

Abstract: A therapeutic agent delivery device includes a syringe assembly having a plunger, a drive mechanism, and a shuttle system coupled to a syringe of the syringe assembly. The drive mechanism includes a motor and a lead screw to engage the plunger, and a controller configured to facilitate movement of the shuttle system distally relative to the syringe assembly and movement of the syringe distally to extend a needle from the therapeutic agent delivery device. The lead screw can drive the plunger for drug delivery. Rotation of the lead screw after the plunger is driven can facilitate retraction of the lead screw from the plunger and facilitate movement of the shuttle system proximally and the syringe proximally relative to the syringe assembly. The drive mechanism and the shuttle system may be an integrated assembly.

Abstract: The invention is a browser user interface generating a new class of smart legal contracts electronic documents for traditional, natural-language, legally-binding agreements; wherein invention electronic document generation includes blockchain API wallet signing of digital asset transactions generating PDF downloads with transaction hash links to the blockchain ledger network. Invention user interface is fully browserified wherein the smart legal contract tokenization, payment, trustline, hook, and escrow blockchain transactions are integral to the electronic document programming of its direct peer to peer API transactions with the blockchains, for example XRP Ledger (XRPL) transactions with Xaman API wallet signing. Hence invention features the three conditions needed to formalize the intent of binding written contracts: subject, consideration, and capacity, while incorporating blockchain safeguards against the product of forgery or perjury sought by Uniform Commercial Code.

Abstract: A deodorant composition comprising a magnesium salt and an aqueous carrier, wherein the deodorant composition is substantially free of aluminum.

Abstract: Disclosed are conjugates including a recognition element covalently bonded to or linked through a linker to a payload. The payload is a pharmaceutical agent (e.g., an antineoplastic agent, anti-infective agent, or anti-inflammatory agent) or a diagnostic agent. Also disclosed are methods of using the conjugates.

Abstract: A therapeutic agent delivery device includes a disposable portion and a reusable portion that detachably carries the disposable portion. The reusable portion includes a drive mechanism having a guide, a rotary actuator, and a follower drivably coupled to the rotary actuator and movably coupled to the guide. The rotary actuator is actuatable to rotatably drive the follower, and the follower thereby follows the guide and translates the drive mechanism. The drive mechanism thereby translates a syringe assembly of the disposable portion from a stowed configuration to a deployed configuration.

Abstract: A deodorant composition comprising a metal oxide; a primary emollient; and at least one wax with a melting point above 50° C.; wherein the composition is anhydrous and aluminum-free; and wherein the composition has a pH greater than about 8.0 at 60 minutes as measured by the pH Release Test Method.

Abstract: A therapeutic agent delivery system (10) includes a housing (16) and a drive wheel (38) rotatably carried by the housing. A plunger rod (50) may be rotatable with the drive wheel relative to the housing from a first rotational configuration to a second rotational configuration. The plunger rod may be translatable relative to the housing from a first translational configuration to a second translational configuration. A plunger restraint (58) may maintain the plunger rod in the first translational configuration when the plunger rod is disposed in the first rotational configuration. The plunger restraint may permit the plunger rod to translate to the second translational configuration when the plunger rod is disposed in the second rotational configuration. A needle may move from a stowed configuration to a deployed configuration by the plunger rod when the plunger rod moves from the first translational configuration to the second translational configuration.

Abstract: A computer system provides at least one workspace as a user interface corresponding to a user-generated topic. A home topic is provided to the user as an initially selected topic. The home topic provides a workspace to the user as a user interface. User selection of a first topic within the home topic causes designation of the first topic as the current topic. A first workspace is associated with the first topic, and a first topic data structure associated with the first topic is generated and the first topic data structure is associated only with application windows, files and application related data used by the user while the first topic is designated as the current topic. The user is provided, within the first workspace, only application windows, files and application related data used by the user while the first topic is designated as the current topic.

Abstract: A therapeutic agent delivery device includes a disposable portion and a reusable portion that detachably carries the disposable portion. The reusable portion includes a drive mechanism having a guide, a rotary actuator, and a follower drivably coupled to the rotary actuator and movably coupled to the guide. The rotary actuator is actuatable to rotatably drive the follower, and the follower thereby follows the guide and translates the drive mechanism. The drive mechanism thereby translates a syringe assembly of the disposable portion from a stowed configuration to a deployed configuration.

Abstract: Disclosed herein are acylated active agents and methods of their use, e.g., for modulating an autoimmunity marker or for treating an autoimmune disorder.

Abstract: The invention relates generally to tRNA-based effector molecules and methods relating thereto.

Abstract: A deodorant composition comprising a metal oxide; a primary emollient; and at least one wax with a melting point above 50° C.: wherein the composition is anhydrous and aluminum-free; and wherein the composition has a pH greater than about 8.0 at 60 minutes as measured by the pH Release Test Method.

Abstract: Provided are therapeutic compositions containing microbial populations for prevention, treatment and reduction of symptoms associated with a dysbiosis of a mammalian subject such as a human.